96 related articles for article (PubMed ID: 7715574)
1. A spreadsheet technique for dosimetry of transperineal prostate implants.
Feygelman V; Noriega BK; Sanders RM; Friedland JL
Med Phys; 1995 Jan; 22(1):97-100. PubMed ID: 7715574
[TBL] [Abstract][Full Text] [Related]
2. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
Chen Z; Deng J; Roberts K; Nath R
Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
[TBL] [Abstract][Full Text] [Related]
3. The impact of edema on planning 125I and 103Pd prostate implants.
Yue N; Dicker AP; Nath R; Waterman FM
Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CT- and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software.
Siebert FA; Kohr P; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):96-101. PubMed ID: 16447016
[TBL] [Abstract][Full Text] [Related]
6. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
[TBL] [Abstract][Full Text] [Related]
7. Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time-resolving edema.
Monajemi TT; Clements CM; Sloboda RS
Med Phys; 2011 Apr; 38(4):2289-98. PubMed ID: 21626964
[TBL] [Abstract][Full Text] [Related]
8. Examining the relationship between pre- and postimplant geometry in prostate low-dose-rate brachytherapy and its correlation with dosimetric quality using the similarity concept.
Todor DA; Anscher MS; Karlin JD; Hagan MP
Brachytherapy; 2014; 13(5):471-80. PubMed ID: 25037911
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
10. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.
Chen Z; Yue N; Wang X; Roberts KB; Peschel R; Nath R
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1405-19. PubMed ID: 10889396
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
Moerland MA; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
[No Abstract] [Full Text] [Related]
14. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
Lindsay PE; Van Dyk J; Battista JJ
Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
16. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
Duggan L; Bucci J; Kron T
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
[No Abstract] [Full Text] [Related]
17. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy.
Prete JJ; Prestidge BR; Bice WS; Dubois DF; Hotchkiss LA
Radiat Oncol Investig; 1998; 6(2):90-6. PubMed ID: 9572685
[TBL] [Abstract][Full Text] [Related]
18. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
[TBL] [Abstract][Full Text] [Related]
19. Impact of oedema on implant geometry and dosimetry for temporary high dose rate brachytherapy of the prostate.
Kiffer JD; Schumer WA; Mantle CA; McKenzie BJ; Feigen M; Quong GG; Waterman FM
Australas Radiol; 2003 Jun; 47(2):172-6. PubMed ID: 12780447
[TBL] [Abstract][Full Text] [Related]
20. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants.
Nath R; Roberts K; Ng M; Peschel R; Chen Z
Med Phys; 1998 Dec; 25(12):2293-307. PubMed ID: 9874821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]